Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 2451-2455, October 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levin, V. A.
Right arrow Articles by Oliverio, V. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levin, V. A.
Right arrow Articles by Oliverio, V. T.

The Uptake, Distribution, and Antitumor Activity of 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea in the Murine Glioma

Victor A. Levin, William R. Shapiro, Thomas P. Clancy and Vincent T. Oliverio

Laboratory of Chemical Pharmacology, National Cancer Institute, NIH, Bethesda, Maryland 20014

The antitumor activity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) against the murine ependymoblastoma, glioma 26, and glioma 261 was compared with the uptake and distribution of the 14C-labeled drug in the murine ependymoblastoma. With a modified Wilcoxon rank-sum test, it was found that CCNU increased life-span in tumor animals from 2- to 4-fold, depending on the dose used and the particular tumor type studied. Uptake and distribution studies of CCNU-14C in intracerebral and subcutaneous tumors, brain adjacent to tumor, and distant (normal) brain indicated that the parent drug had relatively constant tissue/plasma ratio levels. Of the ether-soluble fractions, CCNU had a tissue/plasma ratio of greater than 4 and accounted for 15% of the ether-soluble radioactivity. From the data, it was concluded that the antitumor activity of CCNU is probably independent of preferential uptake of distribution between normal and tumor tissue. Although few conclusions concerning the mode of action of CCNU on gliomatous tumors can be made, nevertheless further consideration of its use in the treatment of human gliomas seems warranted.

Received 9/29/69. Accepted 6/ 3/70.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
B. D. Ross, Y.-J. Zhao, E. R. Neal, L. D. Stegman, M. Ercolani, O. Ben-Yoseph, and T. L. Chenevert
Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: An MRI study
PNAS, June 9, 1998; 95(12): 7012 - 7017.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.